School of Health and Human Sciences, Southern Cross University, PO Box 154, Lismore, NSW, 2480, Australia.
School of Health and Human Sciences, Southern Cross University, PO Box 154, Lismore, NSW, 2480, Australia.
Complement Ther Med. 2020 Mar;49:102317. doi: 10.1016/j.ctim.2020.102317. Epub 2020 Jan 16.
Complementary medicines (CM) are widely consumed by Australians. However, CM is not included in policy and planning of patient-centred models of healthcare. This study aimed to explore how patients themselves manage to integrate CM with mainstream healthcare.
An online survey was distributed through snowball sampling via professional networks and targeted advertising in social media to Australian consumers of CM. Data were managed in Excel and analysed using descriptive statistics in IBM SPSS v23 and Stata v13.
A total of 379 consumers of CM therapies or products completed the survey. The mean age was 51 years, 83% were female and 34% reported having a chronic disease. CM consumers consulted a wide range of healthcare providers. Almost all (97%) had seen a general medical practitioner (GP) within the past year. Overwhelmingly, participants (95%) reported that they themselves were the primary managers of their own healthcare, either on their own (60%) or in collaboration with a CM practitioner (19%) or GP (16%). Approximately 60% of participants reported that they freely discussed their visits to CM practitioners with their GP. Among those, however, males with chronic disease were less likely to disclose CM practitioner consultations (X = 4.1, p = 0.04) and over-the-counter pharmaceutical consumption (X = 3.8, p = 0.05) to GPs than males without chronic disease. Small numbers in some subgroup analyses suggested that further, larger studies on patient perspectives should particularly target males with chronic disease. Most respondents (83%) valued free choice of health practitioner as extremely or very important (83%). A sense of practitioner community was extremely or very important to the majority (76%) of participants.
CM consumers see themselves as primary managers of their healthcare. They want more communication between healthcare providers, which could support them in the safe integration of their total healthcare options. Healthcare policy and planning should recognise the totality of influences on patient health, including the range of CM practitioners and products used by some healthcare consumers.
补充药物(CM)在澳大利亚被广泛使用。然而,CM 并未包含在以患者为中心的医疗保健模式的政策和规划中。本研究旨在探讨患者自身如何将 CM 与主流医疗保健相结合。
通过专业网络的滚雪球抽样和社交媒体的定向广告,向澳大利亚 CM 消费者在线分发问卷。数据在 Excel 中管理,并使用 IBM SPSS v23 和 Stata v13 进行描述性统计分析。
共有 379 名 CM 治疗或产品的消费者完成了调查。平均年龄为 51 岁,83%为女性,34%报告患有慢性病。CM 消费者咨询了广泛的医疗保健提供者。几乎所有人(97%)在过去一年中都看过全科医生(GP)。绝大多数参与者(95%)报告说,他们自己是自己医疗保健的主要管理者,要么独自管理(60%),要么与 CM 从业者(19%)或 GP(16%)合作管理。大约 60%的参与者报告说,他们会自由地与 GP 讨论他们去 CM 从业者的就诊情况。然而,患有慢性病的男性不太可能向 GP 透露他们去 CM 从业者的就诊情况(X=4.1,p=0.04)和非处方药物的使用情况(X=3.8,p=0.05),而没有慢性病的男性则会透露这些情况。在一些亚组分析中,小数量的参与者表明,应该特别针对患有慢性病的男性进行更多的、更大规模的关于患者观点的研究。大多数受访者(83%)认为自由选择医疗从业者非常重要或极其重要(83%)。大多数参与者(76%)认为从业者社区非常重要或极其重要。
CM 消费者认为自己是医疗保健的主要管理者。他们希望医疗服务提供者之间有更多的沟通,这可以帮助他们安全地整合他们的全部医疗保健选择。医疗保健政策和规划应认识到影响患者健康的各种因素,包括一些医疗保健消费者使用的 CM 从业者和产品的范围。